Mirati Therapeutics, Inc. EBITDA 2013-2023 | MRTX
Mirati Therapeutics, Inc. ebitda from 2013 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Mirati Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-761 |
| 2021 | $-567 |
| 2020 | $-369 |
| 2019 | $-225 |
| 2018 | $-104 |
| 2017 | $-72 |
| 2016 | $-84 |
| 2015 | $-64 |
| 2014 | $-38 |
| 2013 | $-32 |
| 2012 | $-20 |
| 2011 | $-10 |
| Mirati Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-177 |
| 2023-06-30 | $-192 |
| 2023-03-31 | $-198 |
| 2022-12-31 | $-215 |
| 2022-09-30 | $-187 |
| 2022-06-30 | $-176 |
| 2022-03-31 | $-183 |
| 2021-12-31 | $-195 |
| 2021-09-30 | $-78 |
| 2021-06-30 | $-163 |
| 2021-03-31 | $-131 |
| 2020-12-31 | $-106 |
| 2020-09-30 | $-89 |
| 2020-06-30 | $-85 |
| 2020-03-31 | $-90 |
| 2019-12-31 | $-75 |
| 2019-09-30 | $-58 |
| 2019-06-30 | $-49 |
| 2019-03-31 | $-44 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-29 |
| 2018-03-31 | $-15 |
| 2017-12-31 | $-18 |
| 2017-09-30 | $-17 |
| 2017-06-30 | $-19 |
| 2017-03-31 | $-18 |
| 2016-12-31 | $-20 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-22 |
| 2016-03-31 | $-22 |
| 2015-12-31 | $-18 |
| 2015-09-30 | $-19 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-12 |
| 2014-12-31 | $-10 |
| 2014-09-30 | $-10 |
| 2014-06-30 | $-10 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-9 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-8 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-6 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-3 |
